February 11 2021
General, R&D

Businesses Spent This Much More on R&D at Capital Region Colleges and Universities

R&D funded by businesses up 51% at RPI, 39% at SUNY Poly Increased business funding helped fuel a 6.9 percent increase in research and development spending at Capital Region colleges and universities in 2019, according to a Center for Economic Growth (CEG) analysis of new data from that National Center

February 8 2021
Clean Technology, R&D

The Research Connection – February, 2021: Climate Change Edition

Featured university R&D projects: Detecting abandoned gas wells New tool to visualize climate change Next generation perovskite solar cells Integrating solar energy into the power grid Changing the way buildings use energy A green approach to the plastic pollution crisis app Energizing the future Engineering a better world using mirrors,

January 12 2021
R&D

Capital Region’s Academic R&D Footprint Spans 1.5M Square Feet

Skidmore set to double R&D space with CIS, Ualbany preps ETEC for June opening The Capital Region’s academic research and development footprint spanned 1.5 million square feet in 2019 and promises to stretch farther with several building projects in the pipeline. Most notably among those developments are the University at

January 12 2021
R&D

Capital Region Businesses Spent $1B+ on R&D in 2018

Capital Region businesses continue to spend more than $1 billion on research and development, making it one of only 51 metros nationwide to surpass that threshold, according to a Center for Economic Growth (CEG) analysis of new data from the National Center for Science and Engineering Statistics (NCSES). R&D spending

January 12 2021
Biotechnology/Life Sciences/Pharmaceuticals, General, News, R&D

Capital Region Nets $81.5M in NIH Awards – Most in 12 Years

FOR IMMEDIATE RELEASE GE Research receives record amount of NIH awards, Union prof’s neuro-exergame in clinical trials   ALBANY, NEW YORK – In fiscal 2020, the Capital Region’s Life Sciences Cluster received its greatest amount of National Institutes of Health (NIH) awards in 12 years, when adjusting for inflation. The

November 10 2020
Biotechnology/Life Sciences/Pharmaceuticals, COVID-19, Manufacturing, R&D

The Research Connection – November, 2020: COVID-19 Edition

Featured university R&D projects: 30-Minute COVID-19 Antibody Test Unique System for Using UVC Light to Sterilize Masks in Bulk Diagnostic Saliva COVID-19 Test Rapid Corona Virus Testing Engineers Developing New Ways to Optimize N95 Masks COVID-19 Pooled Surveillance Testing Program Streamlined Temperature Screening System UB facilities used to develop COVID-19

October 13 2020
Advanced Materials, Nanotechnology, News, R&D

NY Capital Region Inventors Listed on 1,400+ Semiconductor Device Patents in 2019 – up 8%

FOR IMMEDIATE RELEASE More Semiconductor Innovation attributable to Capital Region than Any State except CA ALBANY, NEW YORK – As the semiconductor industry rallies to increase domestic chip production, Capital Region inventors are driving even more innovation to support that re-shoring movement. In 2019, the U.S. Patent and Trademark Office

August 11 2020
Biotechnology/Life Sciences/Pharmaceuticals, General, R&D

The Research Connection – August 2020: Cancer Research Edition

Featured R&D projects: Transfer RNAs in Cancer Improving Targeted Therapies against Solid Tumors Targeting the Chaperone of Kidney Cancer Choice of anesthesia may affect breast metastases New inhibitor shows promise against metastatic prostate cancer A Tumor Model that More Closely Mimics the Body Protein Linked to Cancer Acts as a

July 17 2020
Advanced Materials, Manufacturing, Nanotechnology, R&D

CEG Continues to Represent the Capital Region at SEMICON West – Now Virtually

Regional industry attraction efforts continue despite COVID-19 The coronavirus pandemic will not be stopping the Center for Economic Growth from promoting the Capital Region’s innovation assets and manufacturing capabilities at the nation’s leading semiconductor industry event. Except instead of traveling to San Francisco to attend the 50th annual SEMICON West,

May 5 2020
Biotechnology/Life Sciences/Pharmaceuticals, COVID-19, R&D

Capital Region Life Sciences Cluster Mobilizes to Counter COVID-19

From conducting clinical trials to developing testing equipment and medical devices, the Capital Region’s Life Sciences Cluster is contributing to the effort to fight the coronavirus pandemic. The Life Sciences Cluster employs more than 5,800 and features several industries that are nationally unique. Below is an overview of COVID-19-related activates

Funding Partners